Background/Objectives: The hallmark of cystic fibrosis (CF) is chronic lung inflammation. The severity of lung disease is closely correlated with immunoglobulin G (IgG) levels. Beyond its contribution to the bone health, the importance of vitamin D has not been fully recognized owing to the lack of human studies providing evidence of its benefit. In the context of the recently described immunomodulatory functions of vitamin D, we aimed to assess the relationship between vitamin D and IgG levels. Subjects/Methods: Eight hundred and ninety-six CF patients were included (0.53-65.9 years) from seven centers in Denmark, Norway and Sweden. Serum 25-hydroxyvitamin D (25OHD) and total IgG were measured, spirometry was carried out and vitamin D intake data were gathered using a 7-day dietary food record. Multiple linear regression analyses were performed for IgG and forced expiratory volume in 1ls (FEV1) as dependent variables, and serum 25OHD, daily food and supplemented vitamin D sources of intake as independent variables. The model was controlled for age, gender, genotype, CF-related diabetes, season, infection/colonization status, long-term oral corticosteroid treatment, long-term treatment with macrolide antibiotics, pancreatic insufficient phenotype and body mass index z-score. Results: Serum total IgG levels were negatively associated with serum 25OHD (adjusted R 2 ¼ 0.376; beta ¼ À0.02; Po0.001), supplemented vitamin D intake per kg bodyweight (adjusted R 2 ¼ 0.375; beta ¼ À0.82; Po0.001) and total vitamin D intake per kg bodyweight (adjusted R 2 ¼ 0.398; beta ¼ À0.60; P ¼ 0.002). Serum 25OHD was positively associated with FEV1 (adjusted R 2 ¼ 0.308; beta ¼ 0.0007; P ¼ 0.025). Conclusions: Increasing vitamin D intake may positively modulate inflammation in CF. This study supports the proposed role of vitamin D in the immune system during infection and substantiates prospective studies.
Introduction
Cystic fibrosis (CF) is the most common life-shortening autosomal recessive condition in Caucasians. Progressive pulmonary disease is the major cause of morbidity and mortality in CF patients. Both the severity of lung disease and long-term prognosis are closely correlated with total immunoglobulin G (IgG) levels in children and adults with CF (Wheeler et al., 1984; Levy et al., 2007) . Bacterial infection and chronic colonization of the lungs are the primary stimuli for inflammation in the CF airway. The inflammatory process is associated with low levels of the potent antiinflammatory cytokine interleukin-10 (IL-10) in the CF lung (Bonfield et al., 1995) . The infection/colonization persists and, without treatment, irreversibly damages the airways (De Rose, 2002) . Breaking the vicious circle of infection and inflammation with anti-inflammatory agents delays respiratory failure .
Classical function of the active form 1,25-dihydroxyvitamin D is maintaining calcium homeostasis. However, several recent observations have initiated a re-evaluation of the physiological actions of vitamin D (Hansdottir et al., 2008; Mora et al., 2008) . This was followed by subsequent description of 'non-classical functions of vitamin D', which include immunomodulatory properties of vitamin D, firmly supported by numerous in vitro and animal experiments (Bouillon et al., 2008) . The in vitro findings consistently suggest that vitamin D enhances antimicrobial activity at early stages of infection (Liu et al., 2006; Urry et al., 2009) and provides negative feedback at later stages (Sadeghi et al., 2006) . The inhibitory effects of vitamin D on adaptive immune response include induction of the potent antiinflammatory cytokine IL-10. This complex immunomodulatory role of vitamin D has been reviewed in detail elsewhere (Mora et al., 2008) . So far, there are no large human studies on the proposed role of vitamin D in the immune system during infection.
Most CF patients have suboptimal serum levels of 25-hydroxyvitamin D (25OHD) (below 75 nmol/l), despite following the currently recommended vitamin D supplementation regimens (Rovner et al., 2007; Stephenson et al., 2007) . Literature review indicates that vitamin D status of CF populations may have been improving over the last 15 years, but mean 25OHD serum concentration continues to be suboptimal (Hall et al., 2010) . Vitamin D supplementation in CF is given to avoid osteoporosis. Owing to improved treatment of bone disease with bisphosphonates, the level of vitamin D in CF patients worldwide is seldom monitored. In Scandinavia, no specific recommendations for vitamin D supplementation for CF population are followed. There is no evidence for the benefit of vitamin D supplementation in CF patients yet (Ferguson and Chang, 2009) .
We hypothesize that chronic vitamin D insufficiency may contribute to the ongoing CF lung inflammation, which is associated with high IgG levels, low IL-10 levels and poor lung function. The aim of this analysis was to study the relation between vitamin D and serum IgG, and secondarily, between vitamin D and lung function. This was studied in a large, well-characterized Scandinavian CF population.
Materials and methods

Study population
The Scandinavian CF Nutritional Study is a cross-sectional multi-centre study that was initiated to investigate the nutritional status of the Scandinavian CF patients as well as their energy and macronutrient intake data. Seven of the eight CF centers in Scandinavia participated with 898 patients included in the study (Sweden: Stockholm 164, Gothenburg 131, Lund 115, Uppsala 73; Denmark: Copenhagen 236; Norway: Oslo 144, Bergen 35). The Regional Ethics Committees in each country approved the study and informed written consent was obtained from all the adult patients and from parents of all the children.
Patients were included consecutively from 5 September 2003 to 25 May 2006 when in clinically stable condition. Inclusion criteria were confirmed CF diagnosis based on clinical features, repeatedly (X2) positive sweat tests (Cl 460 mmol/l children, 480 mmol/l adults) and/or the presence of a known disease-causing mutation on each CFTR gene. Exclusion criterion was pregnancy.
Methods
The internationally accepted measure of vitamin D status, serum 25OHD, was measured in blood taken at inclusion. The analysis of all the samples was carried out by highperformance liquid chromatography with the ultraviolet detection method at The Research Laboratory, Department of Pediatrics, Haukeland University Hospital, Bergen, Norway. A modified version of the method described by Aksnes (1994) was used. This methodology gives results comparable with both liquid chromatography-tandem mass spectrometry and radioimmunoassay technology (L Aksnes, personal communication; Lensmeyer et al., 2006; Roth et al., 2008) .
Food vitamin D daily intake was obtained by a 7-day food record. Nationally designed and validated pre-coded forms were used, in which household measures and photographs described food portion sizes. All three food records were designed to assess the entire diet over the previous 7-day period, and they have been described in several studies (Becker and Johansson, 1987; Becker et al., 1998; Lillegaard and Andersen, 2005) .
In our study, the patients and/or parents were instructed by a CF dietitian how to complete the food records. Food recording was carried out in patients X4 years of age followed at all the centers in the study, except the CF centre in Gothenburg owing to the lack of resources. Four hundred and six patients completed the food record. Response rates were 86% (115/134), 84% (76/91), 79% (27/34) and 76% (93/122) for Stockholm, Lund, Bergen and Oslo, respectively. The records were coded and analyzed for energy and nutrients. In Sweden, this was carried out at the National Food Administration using the software MATs (Rudans Lättdata) with the database PC-Kost, in Denmark at Danish National Food Institute using the GIES software and in Norway at the Department of Nutrition, University of Oslo using the KBS software.
Supplemented vitamin D daily intake was calculated from the data on the mean daily intake of the different vitamin and mineral supplements by dietitians, who were taking into account forgotten or skipped doses (728 patients). The patients were asked how often they forgot or deliberately Inverse relation between vitamin D and serum IgG T Pincikova et al did not take their supplements and mean daily dose was counted: (daily dose taken Â number of days a week when the dose was taken) divided by 7 days. Total vitamin D daily intake was calculated as the sum of daily food vitamin D and daily supplemented vitamin D (389 patients). Owing to the wide bodyweight (BW) range (7.0-131.0 kg), we further adjusted vitamin D intake as vitamin D intake per kg BW.
IgG was measured at respective hospital laboratories using routine in-house methods of protein electrophoresis.
Lung function test was performed at inclusion (X7 years) by dynamic spirometry at each center. From measured forced expiratory volume in 1ls (FEV1) in liters, percentage of predicted values were calculated using the Solymar and Quanjer reference equations for patients o19 and X19 years, respectively (Solymar et al., 1980; Quanjer and Tammeling, 1983) .
For cytokine analysis, enzyme immunoassay was performed in the sera from 124 randomly chosen patients from Stockholm, according to the manufacturer's instructions: IL-10, High Sensitivity ELISA (Quantikine HS) kit from R&D Systems, Abingdon, UK.
All variables included in the multiple linear regression (MLR) analysis as independent variables were assessed at the inclusion into the study. Patients using pancreatic enzymes were classified as pancreatic insufficient. Z-score body mass index (z-BMI) was used as a measure of nutritional status. Infection/colonization status was considered positive if the patient had positive bacterial/fungal isolate at the time of inclusion. These were patients with either chronic lung infection or current colonization/infection of the airways. Sputum and nasopharyngeal swabs were cultured at each center. In accordance with previous studies at northern latitudes, the summer season was defined as May-October and the winter season as November-April (Snellman et al., 2009) .
Statistical analysis
Univariate linear regression analysis was used to examine the relation between vitamin D and serum IgG levels or FEV1, using the following independent variables: serum 25OHD, total vitamin D intake, total vitamin D intake per kg BW, food vitamin D intake, food vitamin D intake per kg BW, supplemented vitamin D and supplemented vitamin D per kg BW.
MLR analyses were performed for IgG and FEV1 as dependent variables, and serum 25OHD, food and supplemented vitamin D sources of intake as independent variables. To consider possible confounding factors, the model constructed was controlled for age, gender, genotype, CF-related diabetes (CFRD), season, infection/colonization status, long-term treatment with oral corticosteroid, oral long-term treatment with macrolide, pancreatic insufficient versus sufficient phenotype and z-BMI. Categorical variables were coded (gender male 1/female 2; F508del homozygous genotype 0/other genotype 1; winter 0/summer season 1; all other variables: no 0/yes 1 (Table 1) ). All patients enrolled in the Scandinavian CF Nutritional Study were included in the analyses, except patients younger than 6 months, because their IgG levels are predominantly maternally derived.
IL-10 values were log-transformed (ln(IL-10)) to have approximately normal distribution of data. Pearson's correlation analysis was used to determine the relation between serum 25OHD and ln(IL-10).
Statistical analyses used STATISTICA (version 7) and SPSS (version 17). All tests were two sided and Po0.05 was considered statistically significant.
Results
Among the 896 Scandinavian CF patients aged 0.53-65.9 years, the mean serum 25OHD was 52.0 nmol/l (range: 1.5-206.9 nmol/l). Data on serum 25OHD were available for 787 patients; of these, 84% had suboptimal 25OHD level (o75 nmol/l). The estimated median total daily vitamin D intake was 17 mg (680 IU). Majority of the patients were using pancreatic enzymes, were not born with meconium ileus, did not have CFRD diagnosis and were not on long-term oral corticosteroid or macrolide treatment (Table 1 ). In this patient data set, serum 25OHD levels were not determined by latitude zone (zone 1: 541-591; zone 2: 601-651; zone 3: 661-711 North) or by belonging to a specific CF centre (NS).
Univariate linear regression analyses showed significant negative correlations between IgG and 25OHD, food vitamin D intake per kg BW, supplemented vitamin D intake, supplemented vitamin D intake per kg BW, total vitamin D intake and total vitamin D intake per kg BW (Supplementary Table 1 Figure 3) . None of the various vitamin D sources of intake showed significant relation to FEV1 in this model (Supplementary Table 4 ).
Pearson's correlation analysis revealed no statistically significant correlation between serum 25OHD and logtransformed IL-10 serum level in 124 randomly chosen CF patients from Stockholm (r ¼ 0.053; P ¼ 0.561).
Discussion
Our study was performed in a large cohort of CF patients, treated in specialized Scandinavian CF centers and living at northern latitudes (541-711 North). Most of them had suboptimal serum 25OHD concentration. This finding is in line with studies of other CF patient populations (Rovner et al., 2007; Stephenson et al., 2007; Neville and Ranganathan, 2009) . With supplementation or UV-B exposure, 25OHD could, however, be safely increased over time (Stephenson et al., 2007; Khazai et al., 2009; Neville and Ranganathan, 2009 
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The wide range of serum 25OHD levels in our sample population (1.5-206.9 nmol/l), the relative homogeneity of the patient sample with regard to treatment strategies and lifestyle, and the chronic inflammation as common characteristics of all the patients render our study population sensitive for studying the proposed immunomodulatory effect of vitamin D. Our study raises the question whether vitamin D insufficiency may contribute to the progress of the airway infection/inflammation in CF. In support of this hypothesis, our data have shown 25OHD to be inversely related to serum total IgG and positively related to FEV1. Furthermore, we found that supplemented vitamin D per kg BW and total vitamin D intake per kg BW were also inversely related to serum total IgG. This supports the notion that low 25OHD levels and high IgG levels are not merely markers of disease severity, but rather causally related, since if anything pancreatic insufficient patients, who are more severely ill than pancreatic sufficient patients, are recommended more intensively to take vitamin supplementation. This interpretation is well compatible with our finding that supplemented vitamin D per kg BW and total vitamin D intake per kg BW were strongly related to serum IgG in our model, but they failed to show any connection with FEV1, which reflects the severity of the lung disease in CF. On the other hand, serum 25OHD was associated with FEV1. Theoretically, more severely ill patients might spend more time outdoors and thus have higher serum 25OHD. However, the associations of vitamin D intake variables cannot be subjected to the same criticism. Importantly, the associations found were clinically relevant as regards the IgG concentration per se. Therefore, we can state that the consistent association between IgG and several vitamin D variables is a strong indication of the importance of vitamin D for immune regulation.
The vitamin D intake in the form of food only did not prove to be a significant determinant of serum IgG Inverse relation between vitamin D and serum IgG T Pincikova et al concentration. However, food vitamin D constituted only 27% of the total vitamin D intake in our patient group, in spite of the fact that margarines, butter and low-fat milk are fortified with vitamin D both in Sweden and Norway. In addition, none of the food records used to assess the vitamin D intake in food had been validated for vitamin D intake, implying that the precision of the assessment might be limited. FEV1 is the best surrogate outcome measure in CF, with little within-subject variability and high relative precision (Cooper et al., 1990; Kerem et al., 1992) . Serum total IgG levels represent a marker of the chronic inflammatory process in CF and correlate inversely with the patients' lung function and long-term prognosis (Wheeler et al., 1984; Levy et al., 2007) . Therefore, data were analyzed using the same MLR model for both IgG and FEV1 as dependent variables. FEV1 decreases and IgG increases with factors contributing to lung morbidity and overall mortality in CF. These were consistently shown to be age, female gender, pancreatic insufficient phenotype, infection/colonization, worse nutritional status (Konstan et al., 2007) , F508del homozygous genotype (Kerem et al., 1990) and additional diagnosis of CFRD (Schaedel et al., 2002) . On the contrary, IgG and FEV1 were reported to decrease and increase, respectively, upon treatment with anti-inflammatory agents, such as oral steroids (Auerbach et al., 1985) , and are most likely being positively influenced by the recently documented immunomodulatory effect of macrolides (Shinkai et al., 2008) . At northern latitudes, vitamin D cannot be synthesized in the skin between late autumn through April (Webb et al., 1988) . Therefore, a season variable was included in the MLR model. In our MLR model with 25OHD as independent variable, we have confirmed age, serum 25OHD, infection/colonization status and nutritional status assessed by z-BMI as significant determinants of both serum total IgG and lung function measured by FEV1. In addition, gender, steroid treatment and macrolide treatment were identified as risk-indicator variables for serum total IgG levels. Long-term treatment with macrolide antibiotics was previously shown to positively affect lung function (Hansen et al., 2005; Anwar et al., 2008) and exert complex immunomodulatory effect (Shinkai et al., 2008; Steinkamp et al., 2008) , which justified inclusion of this variable into our model. Surprisingly, macrolide treatment showed a positive and a negative relation to serum total IgG and FEV1, respectively, probably as a result of selection bias and little immunomodulatory effect. Importantly, season did not show to be a determinant of serum total IgG or FEV1, which indicates that it is rather 25OHD level per se that is associated with the studied outcome variables, and not season as such. These results suggest that season might be associated with serum total IgG or FEV1, but only if it influences serum 25OHD levels.
Several previous studies have addressed the relation between vitamin D status and lung function. These have found a positive association between serum 25OHD and FEV1. However, analyses were either not controlled for any confounders or controlled for only a few relevant factors, despite the substantial heterogeneity within the subject population (Black and Scragg, 2005; Green et al., 2008; Wolfenden et al., 2008) . The positive association between 25OHD and FEV1 in our MLR model confirmed these previous observations in our large population of well-defined patients. The absolute amplitude of the association in this model is small. This is not surprising in the context of the well-described other, stronger lung function determinants in this patient group, all of which are included in our model together with vitamin D. Therefore, despite the considerable support for the concept of vitamin D as an immunomodulator provided by this study, the clinical relevance of this finding remains unclear.
In search for the underlying mechanism behind the inverse relation between 25OHD and serum IgG, we subsequently analyzed 124 randomly chosen sera from the Stockholm CF patients and determined IL-10 level. Vitamin D has been shown to induce the production of IL-10 in vitro (Xystrakis et al., 2006; Mora et al., 2008) . We did not observe any correlation between serum 25OHD and IL-10. However, vast majority of the randomly chosen sera samples had suboptimal 25OHD concentrations and serum IL-10 might not necessarily reflect IL-10 level in epithelial lining fluid in the lung.
If the observed probable immunomodulatory effect cannot be explained by increase in IL-10 levels, there are several other mechanisms of vitamin D immunomodulation, which may be related to it. Expression of CYP27B1, a 25OHD-activating enzyme, has been reported in normal human respiratory epithelial cells (Hansdottir et al., 2008) , and active vitamin D has been found to induce antimicrobial peptide expression in CF bronchial epithelial cells (Yim et al., Inverse relation between vitamin D and serum IgG T Pincikova et al 2007). Moreover, vitamin D was shown to inhibit primarily production of the proinflammatory cytokines by adaptive immune cells and to decrease B-cell proliferation, plasmacell differentiation and IgG secretion (Mora et al., 2008) . We speculate that this direct effect on antibody production might explain our findings to some extent.
In conclusion, our study suggests that increasing vitamin D intake is likely to modulate positively inflammation in CF. Future research should focus on intervention studies to test whether the associations represent causal relationships. Our findings clearly indicate that elaborate prospective studies with hard end points are fully justified to assess the amplitude of the absolute clinical benefit of vitamin D supplementation.
